Optimization of novel lead compounds for the treatment of African trypanosomiasis using innovative medicinal chemistry and formulation. ua_30260
Dynamics and mechanisms of paromomycin and miltefosine drug-resistance in the protozoan parasite Leishmania. ua_26346
Identifying factors involved in miltefosine or amphotericin B treatment failure in visceral leishmaniasis. ua_33475
Veterinary and human parasitology. ua_33049
INFLA-MED - Fundamental research in the pathophysiological processes of inflammatory diseases. ua_31391
Publication type
|
|
|
|
|